Celgene Corp. sell-side analysts can’t agree on what’s next for the company with shares hovering near a four-year low. The Summit, New Jersey-based …
The payoff for Celgene is distant, too. A series of missteps, notably the refusal-to-file letter for ozanimod, have tarnished the big biotech’s image, raising questions …
Celgene (CELG) is up 1.2% to $78.60 after authorizing a $3 ... Teresa Rivas AbbVie (ABBV) is down 1% to $104.55 after Goldman Sachs removed the stock from its …
HAMBURG, Germany--(BUSINESS WIRE)--May 22, 2018--Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that Evotec and Celgene Corporation ("Celgene") have entered into a long-term …
As a result of these false statements and/or omissions, the price of Celgene stock was artificially inflated during the …
Repurchases by top 20 firms at highest in at least a decade Amgen, Pfizer, …
Among the major biotech stocks, Gilead gained 0.41%. Over the past six months, Celgene lost 27.15%, while Alexion gained 10.60% (See the last biotech stock roundup here: Biotech Stock Roundup: ALXN, VRTX Post Solid Results, …
Carlo Cannell increased its stake in Celgene Corp (CELG) by 4.42% based on its latest 2017Q4 regulatory filing with the …